Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans
Status:
NOT_YET_RECRUITING
Trial end date:
2029-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the drug PT150, which blocks glucocorticoid receptor (GR) signaling, for treatment of PTSD in Veterans, and establish a safety and efficacy profile that will inform the design of future studies.
Phase:
PHASE2
Details
Lead Sponsor:
San Diego Veterans Healthcare System
Collaborators:
Pop Test Oncology LLC United States Department of Defense